Total Shoulder Arthroplasty Clinical Trial
Official title:
A Prospective Randomized Controlled Trial to Evaluate the Efficacy of an Interscalene Brachial Plexus Block and Multimodal Analgesia With and Without Liposomal Bupivacaine for Postoperative Pain Control in Total Shoulder Arthroplasty
A double blind, prospective, randomized trial to evaluate postoperative pain, narcotic use, patient satisfaction, and function among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine.
In order to reduce narcotic abuse potential, orthopaedic surgeons have explored multimodal pain regimens in addition to regional anesthesia to improve postoperative pain control. One commonly used intervention to reduce postoperative shoulder pain has been the interscalene brachial plexus block. This block provides significant pain relief for shoulder procedures, but has been limited to less than 24 hours even with long acting anesthetics. In the setting of shoulder arthroplasty, this short-term pain control often leads to the need for increased narcotic pain medication. Since shoulder arthroplasty has been steadily increasing in the United States with an annual growth rate of 10.6%, it is imperative to control patients' postoperative pain without increasing their risk for opiate abuse. A potential method for achieving this is by using liposomal bupivacaine in the interscalene blocks. This study is a double blind, prospective, randomized trial to evaluate the postoperative pain profiles among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine. The purpose of this study is to determine if patients undergoing shoulder arthroplasty with an interscalene brachial plexus block with liposomal bupivacaine (study group) or without liposomal bupivacaine (control group) will have differences in postoperative opiate consumption, patient-reported pain, satisfaction with surgery, and shoulder function. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05900427 -
Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients
|
Phase 4 | |
| Completed |
NCT01430468 -
Patient Specific Instruments Versus Standard Surgical Instruments
|
N/A | |
| Completed |
NCT03730597 -
Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study
|
N/A | |
| Completed |
NCT01782872 -
Analgesia After Total Shoulder Arthroplasty
|
Phase 4 | |
| Completed |
NCT06109415 -
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.
|
Phase 4 | |
| Active, not recruiting |
NCT03623269 -
Posterior Approach to Total Shoulder Arthroplasty
|
||
| Terminated |
NCT03219983 -
Pain Management After Total Shoulder Arthroplasty
|
Phase 4 | |
| Completed |
NCT01726972 -
A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
|
||
| Enrolling by invitation |
NCT06133933 -
Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption
|
||
| Completed |
NCT04855019 -
Post Surgical Pain in Arthroscopic Shoulder
|
N/A | |
| Suspended |
NCT04416932 -
Ultrasound After Total Shoulder Arthroplasty
|
||
| Recruiting |
NCT06143306 -
Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement
|
Phase 4 | |
| Completed |
NCT03887650 -
LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs
|
Phase 4 | |
| Active, not recruiting |
NCT02143245 -
Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections
|
N/A | |
| Completed |
NCT01550952 -
Interscalene Dynamometer Pilot Study
|
N/A | |
| Completed |
NCT04364867 -
Exparel for Total Shoulder Arthroplasty
|
Phase 4 |